跳至主要内容
临床试验/NCT07618676
NCT07618676进行中(未招募)不适用

The 50:50 Nitrous Oxide Challenge: A Prospective Randomised Trial - Needle, Meet Your Match

Institute for Oncology and Radiology of Serbia2 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2025年6月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
62
试验地点
2

研究概览

简要总结

The main goal of the project is to assess pain levels and patient comfort during the administration of a 50:50 Nitrous Oxide/Oxygen gas mixture, in comparison to the same parameters under the standard method used at our institution, which includes injecting a local anaesthetic at the site of planned puncture for central venous catheterisation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who have not previously received Nitrous Oxide.
  • Subjects of both sexes, aged between 18 and 65 inclusive.
  • Subjects who have signed informed consent with full disclosure; no study-related procedure may begin until the subject signs the consent form.

排除标准

  • Infection at the planned puncture site.
  • Pregnancy.
  • Intracranial hypertension.
  • Vitamin B12 deficiency.
  • Hemodynamic instability.
  • Glasgow Coma Scale (GCS) score less than
  • Presence of chronic pain.
  • Neurological disorders.
  • Hematologic disorders.
  • Systemic or intrathecal methotrexate therapy
  • More than two attempts at venous puncture (Subject Withdrawal Criterion).
  • Subject experienced an adverse event requiring early discontinuation (Subject Withdrawal Criterion).
  • Withdrawal of consent by the subject (Subject Withdrawal Criterion)

研究组 & 干预措施

Nitrous Oxide Group

Experimental

This will be the experimental group in which the patients will receive a mixture of gases to assess the efficacy of the treatment compared to the control.

干预措施: Nitrous Oxide-Oxygen (Drug)

Lidocaine 2%

Active Comparator

The control group receiving the standard of care for this intervention.

干预措施: Lidocaine 2% Injectable Solution (Drug)

研究者

发起方
Institute for Oncology and Radiology of Serbia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ana Cvetković

Head of the Department of Anesthesia

Institute for Oncology and Radiology of Serbia

研究点 (2)

Loading locations...

相似试验